Catalyst
Most analysts rate EMR Buy or Strong Buy, showing broad institutional optimism.
Risk
Fund flows show net outflow across all investor size categories indicating potential near-term selling pressure.
Generated at20:1802/06/2026by
Aime
Catalyst
Most analysts rate EMR Buy or Strong Buy, showing broad institutional optimism.
Risk
Fund flows show net outflow across all investor size categories indicating potential near-term selling pressure.